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Contact with an antigenic substance results in a  complex sequence of cellular and 
molecular events, the consequence of which is the acquisition of specifically sensitized 
lymphoid cells. These  sensitized cells can  synthesize and  secrete antibody or react 
with the antigen via cell-mediated-type  reactions. Despite the complexity of immune- 
associated events,  the  orderly process and predictable nature  of many  biochemical 
parameters involved indicate that the response is efficiently regulated. Thus the con- 
trolling mechanisms most likely are also complex, and it is probable that the majority 
have yet to be described. 
One  experimental  means  of  investigating  biological  control  mechanisms  is  the 
use of genetically defined "mutant"  animals.  Such mutants possessing immunologi- 
cally associated genetic differences have  already played important  roles in  under- 
standing  the  intricacies of  the  immune  response.  Guinea pigs which  are either re- 
sponders  or  nonresponders  to  synthetic  antigens  have  facilitated  the  analysis  of 
antigen  recognition  (1  and  references  therein).  Rabbits  have been instrumental  in 
determining the cell source of genetic information for the protein chains of immuno- 
globulins via  allotypic markers  (2,  3).  Different  mouse  strains have  been  used  to 
study the genetic control of the magnitude of the antibody response (1 and references 
therein,  4-9),  the  genetic analysis of  differential responses to  determinants on  the 
same  immunogen  (10-12),  and  the  genetic mapping  of  immune  response  genes  (1 
and references therein). Even though the variety of antigens to which the response is 
genetically influenced in mice is rapidly being enlarged, the immunological cell type 
in  which  the  genetic markers  are  expressed is just beginning to  be  clearly defined 
(12-15). Moreover, mutations have yet to be instrumental in defining cell functions 
or immunological control mechanisms. 
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In a  previous report  (16),  a  culture system was  described in which  the  in 
vitro responses of inbred strains of mice to sheep red blood cells (RBC) 1 did not 
always  parallel  their  in vivo responses.  Although  only a  limited number of 
strains was studied, the relationship of the in vivo-in vitro responses appeared 
to be strain specific. In the present report, the number of strains examined for 
this phenomenon has been extended. The results indicate that (a)  the number 
of plaque-forming cells (PFC) expressed in certain strains after in vivo sensiti- 
zation does not portray the potential number of PFC; (b) three types of strain- 
dependent in vivo-in vitro relationships exist; (c)  a loss or impairment in vitro 
of some mechanism that regulates the extent of PFC production in vivo occurs; 
(d) this loss or impairment is under genetic control; and (e) the in vitro response 
is  controlled by two  unlinked autosomal genes.  Of  the  possible explanations 
which  may  account for  these  findings, evidence is  presented which  suggests 
that the different in vitro responses are not a result of various culture artifacts. 
Materials and Methods 
M/ce.--2-5-month old male inbred, F1 hybrid, or backcross generation mice from our own 
colony were used for ail experiments (female animals were also used in the backcross experi- 
ments). For all in vitro experiments, cells from the spleens of a minimum of three mice of the 
same age were pooled. 
Culture Conditions.--The  culture conditions have been described elsewhere (16). Briefly, 
the mice were killed by cervical dislocation and single cell suspensions were aseptically pre- 
pared from their spleens in cold phosphate-buffered saline (PBS). The cells were washed once, 
after which the mouse RBC were lysed by exposing the cells to distilled water for less than 
5 sec. After this treatment,  the ceils were washed twice and suspended in 0.5 ml of 19BS per 
spleen equivalent. 
Unless indicated otherwise, triplicate cultures of 7.5-8.5 X  106 cells were incubated with 
2 X  107 sheep RBC  (SRBC) of either high  (H)- or low  (L)-stimulator  type  or  2  X  107 
horse RBC  (HRBC)  as the antigen. Cells were cultured  in 35-mm dishes containing 2 ml 
of  a  modified Eagle's-Hanks'  medium supplemented  to  contain  5  X  10  -5 •  2-mercapto- 
ethanol (unless otherwise indicated) and 10% fetal calf serum. The cultures were incubated at 
37°-38°C in a humidified atmosphere of 10% 02-5% CO2--85% N2.  The number of plaque- 
forming cells was assessed for each culture by a modified Jerne assay. Cell viability was deter- 
mined on the day of assay by eosin exclusion. Data are expressed as PFC/106  viable ceils, 
The standard  error within triplicate cultures was in each case less than 15~:;. 
RESULTS 
Strain Dependency of PFC Responses.--Table I shows the in vitro and in vivo 
responses of 13 strains of mice to H-type SRBC. The in vivo responses of the 
strains fell into two classes: low (<300 PFC/106 cells) or high (> 1.500 PFC/106 
cells). Low  responders possessed  the  b  and ja  alleles at  the  major histocom- 
patibility locus (H-2), whereas high responders possessed alleles k, d, q, and be. 
1 A~brevlatlons used in this paper: A cells, accessory cells; B cells, bone marrow-derived cells; 
CI,  coupling index; HRBC,  horse red  blood cells; MET, mercaptoethanol;  PFC, plaque- 
forming cells; PBS, phosphate-buffered saline; RBC, red blood cells; SRBC, sheep red  blood 
cells; T cells, thymus-derived cells. R.  E.  CLICK, L.  BENCK,  B.  j.  ALTER, AND  J.  C.  LOVCHIK  1243 
The magnitude of the responses of spleen cells from the same strains stimu- 
lated  in  vitro  indicates  that  the  strains  were  either  high  (>I0,000),  inter- 
mediate  (4000--8000),  or low responders  (<3000).  Comparison  of the  in  vivo 
and in vitro responses of each strain permits a  further classification. For con- 
TABLE I 
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4-  59 
4-  16 
4-  435 
4-  50 
±  325 
2100  4-  120 
1970 4-  122 
2455  4-  600 
3900 4-  100 
I770  ±  235 
In vitro$ 
Exp. 4-23  2-13 
11,150  (48)[]  H,000  (47) 
21,500  (45) 
10,900  (42) 
10,300  (37)  12,900  (39) 
14,000  (43)  11,000  (41) 
12,000  (44) 
3,660  (56) 
1,370  (56) 
7,850  (35)  5,690  (45) 
1,800  (30)  3,600  (38) 
1,480  (38)  2,260  (32) 
1,030  (30)  1,600  (31)' 
1,400  (30)  2,450  (46) 





13,000  34 
15,200  29 
16,000  31 
5,500  32 
l, 400  26 
1,870  0.7 
4,230 /  3.6 
2,200  1.3 
1,950]  0.9 
2,130  0.8 
1.0 
3~0090  0.8 
7,2201  3.1 
* Animals were injected (intraperitoneally)  with 2.5 X  108 SRBC 4 days before assay. 
:~ Determined after 4 days of culture. 
§ Standard error. 
[[ Numbers in parentheses represent per cent cell viability, i.e. (No. of viable cells recov- 
ered/No, of viable cells seeded)  X  100. 
venience,  this classification is referred  to  by a  coupling index  (CI),  which  is 
defined as the ratio of the response in vitro to that in vivo. A  CI less than  1.5 
was  found  for  BALB/c,  CBA,  C3H,  AKR,  and  129,  which  indicates a  tight 
in  vitro-in  vivo  coupling.  C57BL  and  WC  strains  exhibited  the  largest  CI 
(>25)  implying  an  uncoupled  in  vitro  response.  DBA/2  and  DBA/1,  while 
classified as high responders in vivo, exhibited intermediate responses in vitro; 
their CI of 3-5 indicates a  partial in vivo-in vitro uncoupling. 1244  GENETIC  CONTROL  OF  ANTIBODY  SYNTHESIS  IN  VITRO 
The fluctuation  in cell viability  that  appeared  within  experiments  No. 4-23 
and 2-13 was not strain associated; it was later found to be a result of the  20% 
error  in  the  counting  technique  employed  (17).  In  recent  experiments  (see 
Table IV)  replicate  counting of each  sample has  eliminated  such fluctuations, 
thus  resulting  in comparable cell recovery for all strains. 
Genetic Control.--Results presented  in Table II indicate  the  type of genetic 
control involved in  the in vivo and in vitro responses  of three  F1 hybrids ob- 
tained  by  crossing  a  high  in  vitro  responder  (WC)  to  three  low  in  vitro  re- 
sponders  (AKR,  C3H,  and  BALB/c).  The  in vitro  as  well  as  the  in vivo re- 
sponses  of the  three  crosses were  intermediate.  The  CI of each  indicates  that 
TABLE  II 
Comparison of the Responses of Various F1 Hybrids and Parental Strains  to H-Type  SRBC 
PFC/10~ cells 
Mouse strain  In vitro~  Coupling 
In vivo*  index 
Exp.  1-29  7~2 
WC  440  14,000  12,320  30 
AKR  1970  400  --  < 1 
(WC)  AKR)F1  675  4,500  --  7 
(AKR X  WC)F1  --  5,200  -- 
C3H  2100  --  690  < 1 
BALB/c  1820  --  1,720  < 1 
(WC X  C3H)F1  875  --  4,800  6 
(WC X BALB/c)F1  1280  --  6,000  5 
* Animals were injected (intraperitoneally) with 2.5 X l0  s SRBC 4 days before assay. 
2~ Determined  after 4 days of culture. 
the in vitro responses were all partially uncoupled from their respective in vivo 
responses. 
The number  of genes involved in  the  control  of the  in  vitro  responses  was 
determined  with  a  high  and low responder  (WC  and AKR). The  distributive 
profile is shown in Fig.  1 for the in vitro responses of the two parental  strains, 
F1 hybrids,  and  backcross  animals.  The  minimum  difference  between  the  re- 
sponses  of the  two parental  strains  was fivefold.  The  responses  of F1 hybrids 
were  intermediate  to  those  of  the  parental  strains  and  did  not  overlap  the 
range  of either  parental  response.  Although the lack of overlap is not readily 
apparent for the responses of WC and F1 animals, this is a  result of combining 
the data from three independent experiments,  in which the responses of parent, 
F1  hybrid,  and  backcross  animals  were  lower  in  one  experiment  than  in  the 
other two. The responses of all backcross animals in which AKR was the parent 
fell  within  either the Frresponse  range or the AKR-response range. Although 
not  clearly  shown  (again  because  three  independent  experiments  were  corn- R.  E.  CLICK, L.  BENCK, B..T.  ALTER, AND  J.  C.  LOVCHIK  1245 
bined), within an experiment the responses of the other backcross animals fell 
within the range encompassed by either the F~ or the WC responses. 
Table III summarizes the results of six experiments in which the  segregation 
of the in vitro responses of backcross animals is correlated to the sex and coat 
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t~G. 1.  The immune responses of animals falling within intervals of 500 PFC/106 cells. 
segregate  as expected for two unlinked genes.  ~ The responses of the backcross 
animals were associated with neither sex nor coat color. 
Hypothesis  for In  Vivo-In  Vitro Discrepancies.--Various  hypotheses  can be 
advanced  to  explain the  differences  in  the  relationships of  the  in vivo  and 
2 The segregation data for the backcross descendants of WC were independent of the stimu- 
lator-type of SRBC (H or L). Preliminary experiments (footnote 3) indicate that the in vitro 
responses of the other backcross descendants may segregate differentially against the two types 
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in vitro PFC  responses.  The following experiments  will  focus on one possible 
explanation:  the  phenomenon  is  an  artifact  of  the  culturing  technique  and 
therefore  has  no biological significance.  Various  parameters  tested  that  could 
differentially  affect  the  responses  of  high,  intermediate,  and  low  responders 
were  the  kinetics  of  the  response,  the  dose-response  relationships,  and  the 
requirement for certain culture components. 
Kinetics of the Responses.--To  ascertain whether the culture medium altered 
the response kinetics of different types of responders,  the number of PFC was 
determined  at  different  time  intervals  for  a  high,  intermediate,  and  two low 
TABLE III 
Corrdation  of Sex and Coat Color to the In Vitro  Responses  Against SRBC in Backcross  Des- 
cendants  of WC and AKR 
Backcross  and sex  Coat color 
Number of backcross  animals responding  like 
WC  (WC X  AKR)FI  AKR 
F1 )< WC* 
Female  Black  7  3  0 
Male  "  19  4  0 
Not determined*  "  10  5  0 
Total  36  12  0 
F1 X  AKR§ 
Female  Black  0  2  1 
White  0  0  0 
Male  Black  0  12  4 
White  0  9  5 
Total  0  23  10 
Both males and females were used; the sex was not recorded. 
* The segregation data for this  backcross are a composite of responses to both H- and 
L-type SRBC. 
§ The segregation data for this backcross are for responses to H-type SRBC only. 
responders. As shown in Fig. 2, the shapes of the curves are similar for the four 
strains.  During the first 24 hr the number of PFC increased three- to fivefold. 
The maximum rate  of increase occurred between  days  1 and 3  and thereafter 
declined.  The maximum response occurred between  days 4  and .5.  In addition 
to the differences in magnitude and rate,  the number of background PFC/106 
spleen  cells  in  unimmunized  animals  was  strain  associated;  0.2-0.4  PFC/106 
cells were found in WC and DBA/2 compared to 2-.5 PFC/106 cells present in 
BALB/c and CBA. 
Number of Cells Cultured.--In  vitro antibody synthesis against RBC requires 
three  cell types: thymus-derived (T), bone marrow-derived (B), and accessory 
(A)  cells  (18-20). The possibility that  the high, intermediate,  and low in vitro 
responses of various strains are a consequence of differential survival in culture R.  E.  CLICK~  L.  BENCK~  B.  J.  ALTER,  AND  J.  C.  LOVCttlK  1247 
of these cell types was examined by determining the dose-response dependency 
for different types of responders. As shown in Table IV, as the number of cells 
cultured  was  increased  from 2.8-2.9  X  106  to  approximately 7  X  106, the 
number of PFC increased similarly for all strains irrespective of the antigen. It 
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FIG. 2.  Kinetics of PFC production in vitro. WC, DBA/2, BALB/c, and CBA spleen cells 
were cultured with H-type SRBC for indicated times. 
similar  for  different  types  of  responders  and  similar  for  the  three  antigens 
tested. 
Fig. 3 presents a  log-log plot of selected data from Table IV. The slopes of 
lines in such a plot have been used to estimate the number of cell types inter- 
acting in  a  response  (20).  Transitions  in  the  slopes of such  curves have been 
interpreted to mean that  an upper limit to the  degree of interaction between 
cells has been reached (21). It would be expected, therefore, that major differ- 
ences in the distributions  of T, B, and A  cells in the various responders would 
be indicated by different slopes and by different cell inputs at which transitions 1248  GENETIC  CONTROL  OF  ANTIBODY  SYNTHESIS  IN  VITRO 
occur. As shown, the slopes and points of transitions were similar for the re- 
sponses of WC, DBA/2, and CBA against either H- or L-type SRBC. Likewise, 
the slopes and points of transition were similar for all responses against HRBC. 
The slopes of the responses against HRBC were greater than those found for 
SRBC  at  cell input levels less  than 5  )<  10 6 but were  similar at higher cell 
inputs. Variations in the responses at cell-input levels greater than 8.5  X  10 6 
TABLE IV 
Cell Dose Dependency of Responses to RBC 
Stain 
Number of cells  ....  PFC/10~ cells cultured with* 
cultured (X10  -6) ~en ~oCOVery  H-type SRBC  L-type SRBC  HRBC 
WC  2.85  39  2120  440  350 
4.75  40  8200  1510  2520 
7.60  57  12100  1630  3010 
8.55  54  11400  1810  3500 
10,4  48  11200  1360  4200 
CBA  2.84  32  325  --  8 
4.72  40  845  --  160 
7.55  48  1300  --  295 
8.55  55  1510  --  144 
10.4  54  1560  --  340 
C3H/DiSn  2.86  35  --  74  30 
5.10  37  --  111  126 
6.90  43  --  200  226 
8.55  44  --  345  270 
9.70  45  --  216  318 
DBA/2  2.94  37  --  630  137 
4.90  40  --  1155  1800 
6.85  43  --  1700  2350 
7.90  57  --  1750  1950 
9.80  56  --  695  630 
* Determined against indicated RBC after 4 days of culture. 
ceils are most likely a  result of differences in the lots of culture medium since 
the responses of WC and CBA against HRBC  and H-type SRBC were deter- 
mined in an independent experiment. 
Culture Components.--The culture systems generally used by other investi- 
gators  to  study  "primary"  antibody synthesis  (22,  23)  have  failed  to  show 
the strain-dependent in vivo-in vitro response dichotomy observed under the 
present culture conditions. Even though many of the ingredients of this culture 
medium have been shown to be important for maximum antibody synthesis 
(16),  the  distinguishing component is  the  reducing  agent,  mercaptoethanol 
(MET). Fig. 4 shows the effect of various concentrations  of MET in the medium R.  E.  CLICK, L.  BENCK, B.  ].  ALTER, AND  J-.  C.  LOVCHIK  1249 
on the number of PFC produced by a  low and a  high responder strain against 
H-type SRBC and HRBC. The optimal concentration of MET was 2.5-5.0 X 
10  --5 u  for the response of both strains to both antigens. Although a  slight dif- 
ference  in  optimal  concentration  is  evident  for  the  two  antigens,  repeated 
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SRBC (0  O), and L-type SRBC (© .... ©). 
Other  components  of  the  medium  (nonessential  amino  acids,  glutamine, 
nucleic  acid  precursors)  which  are  necessary  to maximize  the  response  (16), 
similarly affected the responses of various strains to SRBC? 
DISCUSSION 
Genelic ControL--The 13 strains tested against H-type SRBC can be classified 
as high, intermediate,  or low responders in vitro. These responses contrast with 
a Click, R. E., and L. Benck. Unpublished results. 1250  GENETIC  CONTROL  OF  ANTIBODY  SYNTHESIS  IN  VITRO 
those found in vivo; thus an additional classification can be made based on the 
relationship of the in vivo and the in vitro responses. The in vitro responses of 
BALB/c, C3H,  CBA, CBAt6t6,  AKR, and 129 were low and were tightly cou- 
pled to their respective in vivo responses (CI  <  1.5). The responses of DBA/ 
2  and DBA/1 were intermediate in vitro  and  were  partially  coupled to  their 
high in  vivo  responses  (CI  =  3-6).  All  C57  and  WC  strains  were  low  in 
vivo responders and high in vitro responders; thus these strains had the highest 
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FIG. 4.  PFC production at various concentrations of mercaptoethanoi. WC and CBA spleen 
cells were cultured 4 days in the presence of either H-type SRBC or HRBC. It should be noted 
that the PFC response of CBA to SRBC is one-third that of the ordinate scale and  the  PFC 
response of WC to HRBC is 10 times that of the ordinate scale. 
coupling indices  (CI  >  25)  (all  these responses to  SRBC  as well as those  to 
HRBC have previously been demonstrated to be antigen specific [16]). 
The type of genetic control of the in vivo and in vitro responses to SRBC 
appears to depend on gene dosage as suggested by the intermediate responses 
of  (WC  X  AKR)F1,  (WC  X  C3H)F1,  and  (WC  X  BALB/c)F~ hybrids. 
Results obtained with other F1 hybrids  3 suggest that other types of control also 
exist in vivo; e.g., (WC  X  129)F1 hybrids do not respond intermediate to that 
of the two parental strains but, rather, respond as high as the 129 parent. The 
different controlling element operative in this F1 hybrid compared to the other 
three F1  hybrids indicates  that  there  are  at  least  two kinds  of high  in  vivo 
responders. 
The genetic control of the in vitro response to SRBC was further analyzed R.  E.  CLICK,  L.  BENCK~  B.  J.  ALTER,  AND  J.  C.  LOVCI-IIK  1251 
with backcross animals. The segregation of the in vitro responses of (F1 X  WC) 
animals  was  that  expected for two  unlinked  genes;  this  finding  is  consistent 
with  the  report  that  three  genes  control  the  in  vivo  response  to  SRBC  in 
BALB/c and NZB mice (24). The 2.3:1  segregation for the in vitro response of 
(F1 X  AKR) animals indicates that the alleles of each locus show dominance in 
their control of the response. The results also indicate that the products of the 
two genes interact in some manner since (a)  a single dominant allele at either 
locus  resulted  in  a  response  similar  to  that  in  which  both  loci  possessed  a 
dominant  allele,  and  (b)  the presence of two dominant  alleles  at either locus 
resulted in  a  maximum response independent  of the  allele distribution  at  the 
other  locus.  This  conclusion  must  be  somewhat  tentative,  since  an  additive 
effect on the response by the dominant alleles of the two genes most likely would 
not have been detectable because of the difficulty in differentiating a  response 
intermediate to that of the F1 hybrids and parents. The findings do, however, 
rule  out  control  by a  single gene or by two genes,  one of which  is  expressed 
recessively (see appendix in reference 25 for analysis of genetic data). 
The independent segregation of the sex, coat color, and in vitro responses of 
the backcross animals indicate that the genes controlling these phenotypes were 
not  linked.  The  in  vivo  and  in  vitro  responses  were  also  not  influenced  by 
heterozygosity at the W locus or the Steel-Dickie locus. 
Mechanisms  Underlying the  In  Vivo-fn  Vitro  Response Discrepancies.- 
Various hypotheses can be advanced to explain the in vivo-in vitro dichotomy 
and the controlling mechanisms of the unlinked genes. Selective cell growth or 
function does not adequately explain the strain differences. Pertinent findings 
leading to this conclusion are the following. (a) Except for the rate and magni- 
tude of PFC production, the kinetics of the in vitro responses of various strains 
were indistinguishable from one another as well as from their respective in vivo 
responses.  4 (b) The number of cells required to optimize the in vitro responses 
was  similar  for  all  classes  of  responders  against  H-  and  L-type  SRBC  and 
HRBC. (c) The relative distribution of T, B, or A cells in the spleens of various 
responders  was  similar  as  shown  by the  slopes  and  transition  points  of  the 
log dose-log response curves. (d)  The  cell viability after 4  days of culture was 
relatively constant  within  an  experiment for different  strains  (variations  ob- 
served were not strain associated).  (e) The dependency of the response on MET 
was similar for different responders and independent of the antigen. 
The most conclusive argument against the possibility that  culture  artifacts 
underlie  the in vivo-in vitro discrepancies comes from studies now in progress  3 
in  which  the  type of in vitro responses to SRBC  and to HRBC segregate in- 
dependently in backcross animals. In these experiments all culture parameters, 
as  well  as  parameters  related  to  cell-type  distributions  for  each  backcross 
animal, are constant. 
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If  the genetically controlled discrepancy of in vivo and  in vitro responses 
cannot  be  accounted for by culture  artifacts,  it must  be  associated  in  some 
manner with the regulation of the in vivo responses. A similar conclusion has 
been suggested to explain the parallel segregation of the ability to respond to 
many unrelated antigens in Swiss  mice selectively bred for their responses to 
sheep and pigeon RBC  (26). Even though it is not known whether these two 
genetically controlled systems  are  related,  two  possible  explanations  for the 
findings are  (a)  strains  differ in their physiological milieu in which lymphoid 
cells function; or (b) strain variations are a result of differential sensitivity of 
the  lymphoid  ceils  to  a  common suppressive factor. Irrespective of whether 
either alternative is correct, the results indicate a  loss  or impairment in vitro 
of some  mechanism  that  regulates  the  extent  of antibody synthesis  in  vivo. 
Since this mechanism is strain dependent and genetically controlled, it differs 
from other types of control mechanisms postulated for 19S antibody synthesis, 
e.g.,  7S  antibody  feedback  (27,  28)  or  immunosuppression  by  the  factors 
elaborated  as  a  consequence of antigen  competition  (29). Thus,  at least  two 
in vivo control mechanisms must be considered operative in controlling the 19S 
response to an antigen (at least SRBC). One, which all strains possess, controls 
the kinetics of 19S synthesis  (or the time at which  19S  antibody synthesis is 
"shut off"), and the other, which is strain dependent, regulates the magnitude 
of the response. 
Relationship of the Loss of Control In Vitro to Other Genetic Markers.--It is not 
the purpose of this report to define the mechanism by which the ill vivo and 
in vitro responses to SRBC are genetically controlled, yet further understand- 
ing of the phenomenon could be accelerated if systems analogously controlled 
were known. Observations that must be considered in an attempt to correlate 
the present classifications to other parameters are the following.  (a)  All high 
in  vivo  responder  strains  showed  either  tightly  coupled  or  only  partially 
coupled in vitro responses and possessed the tt-2 alleles k, d, q and be.  (b)  All 
low in vivo responders possessed the//-g alleles  b and ja and their in vitro re- 
sponses were uncoupled. (c) The in vitro responses and the CI were not always 
associated with the//-2 alleles,  as demonstrated by the responses of BALB/c 
and DBA/2, both of which possessed the d allele.  (d)  The strain classification 
based on the CI correlated positively with the lg-1  alleles (30)  controlling the 
allotypes of the 7S 3,2A-globulins, that is, all strains possessing the a and d alleles 
had a CI of < 1.5, those having the c allele had a CI of 3-6, and those having 
the b allele had CI >  25. It should be pointed out that the accuracy of these 
correlations must await further documentation in other strains and backcrosses 
in which the segregation of the responses, the//-2 alleles,  and the Ig-1  alleles 
can be determined independently. 
Most  other immune responses that  are genetically controlled are linked to 
various H-2 alleles  (1  and references therein, 4-12), and not to the allotype of 
the gamma-globulins  (5,  31). Of these, only those responses linked to the H-2 R.  E.  CLICK,  L.  BENCK,  B..}.  ALTER,  AND  .}.  C.  LOVCHIK  1253 
alleles b  and k,  such as  those against  (T,  G)-A--L, (H,  G)-A--L  (4)  and the 
mouse  male  transplantation  antigen  (32)  correlate with  the  present  system. 
However, this  correlation with  the  response to the synthetic polypeptides is 
most likely fortuitous since the amount of 7S (rather than 19S)  antibody syn- 
thesized was used to classify the strains against the polypeptides, whereas the 
present system is based on 19S antibody synthesis. 
The one immune response that may be genetically related to the immuno- 
globulin allotype is that in which selective breeding for differential responsive- 
ness to RBC  resulted in  the segregation of genes concerned with the general 
regulation of immunoglobulin synthesis irrespective of the antigen (26). Three 
different allotypic phenotypes were detected in mice of the high responder lines. 
One  resembled  the  BALB/c prototype,  the  second  that  of  C57BL,  and  the 
third was comparable to that of a  (BALB/c X  C57BL)F1 cross in which both 
types of allotypic specificities were present. Of these three, the C57BL prototype 
was not one of those present in the high in vivo responder strains described in 
the present studies. In contrast to the high responder lines, all mice of the low 
responder lines  exhibited  an identical immunoglobulin phenotype which  was 
different from those found in mice of the high responder lines. This allotype was 
probably a  result of a  crossover between  the heavy-chain linkage  groups of 
DBA/2 and Nil prototypes. Likewise, all low responder strains in the present 
studies  possessed  only  one  allotypic  allele,  b.  However,  this  allele  (C57BL 
prototype) was found in  the  high responder selectively bred lines.  Many in- 
terpretations can be advanced to explain these differences; e.g., the two studies 
were measurements of different genetic mechanisms of control (hemolysin was 
used in  the present  classification, whereas hemagglutinin  titers  against  both 
SRBC and pigeon RBC were used to select lines in the breeding studies) ; alter- 
natively, the apparent correlation of the allotype markers and  the control of 
antibody synthesis may be fortuitous. 
One genetically controlled phenomenon that does not appear to be related to 
the present in  vivo-in vitro dichotomy is  hybrid resistance to hematopoeitic 
tissue grafts (33). This conclusion is based on the facts that strains 129, C57BL, 
and  WC  which  have  different CI's  have  all  been  assigned  the  same  hybrid 
resistance allele (Hh-la). This interpretation may, however, be  incorrect  due 
to some pecularities of 1292 and WB (a strain closely related to WC)  (34)  and 
will be dealt with more extensively in a later publication. 
A different type of hybrid resistance recently described (35) correlates better 
with the present findings. In this type of resistance, which is controlled by two 
unlinked genes, strains of mice possessing the same or slight modifications of the 
alleles at the H-2 locus, e.g., 129 and C57BL, differ in their resistance to a third 
strain which possesses an unrelated H-2 allele.  As demonstrated by the present 
results these two strains also differ in their CI's. 
Another  genetically controlled  system  to  which  the  in  vivo-in vitro phe- 
nomenon  may have  relevance is  the  susceptibility  to  disease,  specifically to 1254  GENETIC  CONTROL  OF  ANTIBODY  SYNTHESIS  IN  VITRO 
neoplasia. An example showing a close association with the present controlling 
system is  the differential susceptibility of strains  to  Gross and  Friend virus- 
induced  leukemia,  which is  controlled by two  unlinked  genes for each virus 
(36-38). C57BL, which is refractory to the action of most strains of these two 
viruses, is the lowest responder in vivo, yet the highest in vitro, whereas most 
strains possessing CI's less than 6 (129 being an exception) are generally suscep- 
tible to leukemia induction by one of the two viruses. 
Significance  of the Present Mechanism of Control/or Other Immune Systems.- 
The results of the present report indicate that (a) in certain strains the magni- 
tude of the PFC response arising in vivo does not portray the potential number 
of PFC  (a similar conclusion has been reached from results obtained from cell 
transfer  experiments)  (39);  and  (b)  the in  vitro loss  or impairment  of some 
mechanism  that  regulates  the  extent  of antibody synthesis in  vivo is  under 
genetic control. These two findings limit the conclusions derived from classifi- 
cation of strains based on their in vivo responses. For example, if the observed 
similarity  of  19S  antibody  synthesis  by  low  and  high  responder  mice 
to (T, G)-A--L is not an accurate portrayal of the response potential  of these 
strains, a reconsideration of the hypothesis that the gene defect in nonresponders 
may lie in the marrow-derived precursors of antibody-forming cells instead of 
the favored hypothesis that the It-1  gene is exerted through  thymus-derived 
cells must be entertained. Further, until the importance of the present findings 
is  extended to  the  control  of  7S  synthesis,  other  classifications based  on  7S 
antibody synthesis may also be misleading. 
The  validity  of  the  limiting  dilution  technique  in  enumerating  immuno- 
competent precursors cell frequency can be questioned in view of the control 
mechanisms described in the present report. If it is assumed that the suppres- 
sive environment of recipient mice is unaffected by X-irradiation and, further, 
that the suppressive effect is similar irrespective of the number of cells injected, 
then the frequency of cells participating  in  the events  of  immune  responses 
would be underestimated;  e.g.,  an underestimation up to 30-fold could occur 
in some strains in which SRBC were used as the antigen (40). If, on the other 
hand,  it is  assumed  that  the  suppressive mechanism  affects T,  B,  or A  cells 
differentially or that the degree of suppression is dependent on the number of 
cells inoculated, then the dependency of the response frequencies on the number 
of cells transplanted may not be described by the Poisson model. In fact, such 
findings have been described for transplanted marrow cells in (C57BL X  WB)F~ 
and (C3H X  C57BL)F1 hybrids (40). 
SUM2CfARY 
The finding  that  the  relationship  of the in  vitro and  in  vivo responses  of 
different strains  of mice  is  under  genetic control indicates  that  at  least  two 
mechanisms  must  operate  under  in  vivo conditions  to  control  19S  antibody 
synthesis.  One  is involved in  the  termination  of 19S  antibody synthesis; the R.  E.  C,LICK,  ,L.  BENCK,  B.  J.  A,LTER,  AND  J.  C..LOVCtIIK  1255 
other has a  regulatory role on the magnitude of the response. In light of these 
findings,  various  concepts  based  on  other  genetically  controlled  immune  re- 
sponses  and on  the limiting  dilution  technique  should be  reassessed.  Further- 
more, the suppressive in vivo mechanism may be an important type of contro~ 
in  the  resistance  or  susceptibility  to  the  establishment  or  maintainance  of 
neoplasms. 
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